Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for Immunome (IMNM) over the last 1 years, with Jun 2025 value amounting to 0.04.

  • Immunome's Asset Utilization Ratio rose 12.53% to 0.04 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.04, marking a year-over-year increase of 12.53%. This contributed to the annual value of 0.05 for FY2024, which is N/A change from last year.
  • Immunome's Asset Utilization Ratio amounted to 0.04 in Q2 2025, which was up 5.00% from 0.04 recorded in Q1 2025.
  • In the past 5 years, Immunome's Asset Utilization Ratio ranged from a high of 0.12 in Q4 2023 and a low of 0.04 during Q2 2024.
  • For the 3-year period, Immunome's Asset Utilization Ratio averaged around 0.05, with its median value being 0.04 (2025).
  • In the last 5 years, Immunome's Asset Utilization Ratio tumbled by 68.64% in 2024 and then climbed by 12.53% in 2025.
  • Quarterly analysis of 3 years shows Immunome's Asset Utilization Ratio stood at 0.12 in 2023, then plummeted by 68.64% to 0.04 in 2024, then rose by 12.53% to 0.04 in 2025.
  • Its last three reported values are 0.04 in Q2 2025, 0.04 for Q1 2025, and 0.04 during Q4 2024.